Evgen Pharma Investor Symposium

28 September 2018

Investor Symposium

Evgen Pharma plc (AIM: EVG), the clinical stage drug development company focused on the treatment of cancer and neurological conditions, has held an Investor Symposium for investors and analysts - presentations and further details are available on the Evgen website www.evgen.com/investors/shareholder-information/